Moderna, Inc. is a biotechnology company founded in 2010 that focuses on developing medicines and vaccines using messenger RNA (mRNA) technology. The company aims to harness mRNA science to instruct the body’s cells to produce proteins that can prevent or treat diseases. This innovative approach allows patients to effectively become their own drug manufacturers.

Moderna is well-known for its COVID-19 vaccine, which showcased the rapid development and large-scale manufacturing capabilities of mRNA technology. In addition to COVID-19, the company is developing vaccines for infectious diseases like influenza and respiratory syncytial virus (RSV), with its RSV vaccine approved by the FDA in 2024. Moderna also explores mRNA therapies for cancer, rare diseases, and cardiometabolic conditions, often collaborating with major pharmaceutical companies to enhance its research and development efforts.

The company operates a significant manufacturing and research facility in Norwood, Massachusetts, which supports its preclinical and clinical development. Moderna serves healthcare providers, governments, and public health organizations globally, providing vaccines and therapeutics aimed at improving patient health outcomes.